FDA advisers back sales of stair climbing iBOT wheelchair
FDA advisers unanimously recommended allowing sales of the iBOT 3000 Mobility System, a four wheel drive stair climbing chair with eye level reach. Restrictions include doctor prescription and mandatory training to ensure safe operation. price around 29000 dollars and safety tested with 20 users.
MENTIONED IN THIS ARTICLE
Gaithersburg
Food and Drug Administration
FDA
Ibot
Dean Kamen
Kamen
Johnson & Johnson
Karl Barnard
Tilton, N.H
Steve Stiens
University of Washington
Independence Technology
Also Mentioned on This Page
Barnard
Heikki Austal
New Jersey
Johnson Rehabilitation Institute
the Food and Drug Administration
Sources
Indenen
Cardinals
6Sports
Sunflower
Eudora High
Ft. Scott Tigers